The Future of Medical Automation….. COVID-19 & Its Impact….
The global medical
automation market is expected to
reach USD 79.4 billion by 2024,
according to a new report by Grand View Research, Inc. The increasing demand
for accuracy and reproducibility required during medical procedures is the high
impact rendering driver for the medical automation market.
With Covid-19 infections rising globally, the
apprehension regarding a shortage of essential life-saving devices and other
essential medical supplies in order to prevent the spread of this pandemic and
provide optimum care to the infected also widens. In addition, till a
pharmacological treatment is developed, ventilators act as a vital treatment
preference for the COVID-19 patients, who may require critical care. Moreover,
there is an urgent need for a rapid acceleration in the manufacturing process
for a wide range of test-kits (antibody tests, self-administered, and others).
The report will account for Covid19 as a key market contributor.
The rising adoption of these devices
is attributed to the advantages associated with automated systems. For example,
the automation of tedious tasks such as sampling, monitoring of quality,
quantity, packaging and labeling, and scanning of medicines and devices, have
reduced human efforts and increased speed and accuracy, which has led to
increased dependency on these automated systems.
Moreover, the growing global
prevalence of chronic conditions such as diabetes, cancer, arthritis, and
chronic obstructive pulmonary disease (COPD) is further pushing the demand for
therapeutic, laboratory and pharmacy automated medication systems, which are
faster and more productive. As per the World Health Organization (WHO)
estimates, cardiovascular diseases (CVDs) is the leading cause of mortality
around the globe; in addition, an exponential rise has been witnessed in the
diabetes cases from 108 million in 1980 to 422 million in 2014. The
aforementioned factors are responsible for creating the need for automated medical
equipments over the forecast period.
Furthermore, with the advent of
technologically advanced defibrillators and ablation therapies, this market is
expected to gain swift growth in its market share in the near future. For
instance, automation in the following pharmacy-based functions, medication
dispensing, storage, and retrieval enables traceability and tracking, which in
turn improves patient safety and reduces errors. Furthermore, there is an
increased focus on incorporating automation in hospitals due to the associated
benefits, such as reduction of errors and operational costs; these factors
altogether are expected to present this market with high growth opportunities
in the near future.
To Request Sample Copy of this report, click the link:
Further key findings from the study suggest:
·
The therapeutic segment was
observed to dominate in terms of revenue share in 2015owing to the high usage
rate of automated devices in the non-surgical procedures, such as external
defibrillators, an implantable cardioverter, and wearable/ implantable drug
pumps
·
On the other hand, the medical
logistics and training segment is expected to grow at a lucrative CAGR of over
10.0%. The rising adoption of advanced systems, such as Pneumatic Tube Systems
(PTS) used in material transportation and Real Time Location System (RTLS) in
location-tracking, contributes towards the overall medical automation market
growth during the forecast period.
·
The research laboratories and
institutes segment is also identified as a lucrative segment due to, the rising
demand for automated research laboratories that are helpful in the detection
and the treatment of chronic diseases. These laboratory automated systems help
in reducing demand and supply gaps by mechanization, which yields rapid results
and increases overall productivity. This is expected to further enhance its
usage over the forecast period.
·
With an aim to address the
increasing demand for advanced molecular diagnostic techniques in cancer, the
Leiden University Medical Center have recently succeeded in isolating DNA and
RNA from small tissue samples using a high-throughput, fully automated solution
by Siemens. Innovations like these are expected to present the market with
significant growth opportunities.
·
Some key players in this
industry include Accuray, Inc., Tecan Group Ltd., Medtronic Plc., Swisslog
Holding AG, GE Healthcare, Intuitive Surgical, Inc., Stryker Corporation,
Siemens AG, Koninklijke Philips N.V., and Danaher Corporation.
·
These industry players are
adopting strategies such as technological innovation, new product launches, and
strategic collaborations including mergers and acquisitions to capitalize
untapped opportunities. For instance, in July 2015, Medtronic Plc. acquired RF
Surgical Systems, Inc., for further expansion of its business and with the aim
of capturing a huge market share of the medical automation market in the coming
years.
The global medical automation market was valued at USD 34.21
billion in 2015. The rising prevalence of chronic diseases and the increasing
adoption of automated equipment for diagnosis and therapy are the factors
propelling the market growth.
According to the World Health Organization (WHO) with chronic
diseases being one of the leading factors of mortality in world, chronic
conditions such as cancer, stroke, heart disease, diabetes, and respiratory
diseases cause approximately 60% of the deaths. Moreover, as per NCBI by 2030,
approximately 40.5% of U.S. population is projected to face one or more
cardiovascular diseases, thereby enlarging the consumer base for this market.
The growth over the forecast period is attributed to the growing
demand for accuracy and reproducibility during medical procedures offered by
CyberKnife series and the automated defibrillators for the treatment of cancer.
In addition, the rising automation in laboratories and pharmacies provide
benefits such as cost savings, miniaturization of errors in huge sampling,
speed, and reliability, which is expected to exert a positive impact on the
future demands for medical automation over the forecast period.
Moreover, technological advancements such as robotic radio
surgery systems and automated material handling systems used in the hospitals
are the factors expected to drive the market growth.
Have any Query? Ask our Experts:
Grand View Research has segmented the
medical automation market on the basis of application, end-use:
Global Medical Automation Application
Outlook (Revenue, USD Million, 2014 - 2024)
·
Diagnostic & Monitoring Automation
o
Automated imaging & analysis
o
Point-of-care testing
·
Therapeutic Automation
o
Surgical Automation
o
Non-surgical Automation
·
Lab and Pharmacy Automation
o
Laboratory Automation
o
Pharmacy Automation
·
Medical Logistics and Training
Global Medical Automation End-use
Outlook (Revenue, USD Million, 2014 - 2024)
·
Hospitals & Diagnostic Centers
·
Research Laboratories & Institutes
·
Pharmacies
·
Home & Ambulatory Care
About Grand View Research
Grand View Research, Inc. is a U.S.
based market research and consulting company, registered in the State of California
and headquartered in San Francisco. The company provides syndicated research
reports, customized research reports, and consulting services. To help clients
make informed business decisions, we offer market intelligence studies ensuring
relevant and fact-based research across a range of industries, from technology
to chemicals, materials and healthcare.
Comments
Post a Comment